Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs (Q40332524)

19 September 2017

title

Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs (English)

1 reference

drug reaction with eosinophilia and systemic symptoms

19 September 2017

main subject

1 reference

inferred from title

author name string

Nahuel Pereira de Silva

1

1 reference

19 September 2017

Paulo Piquioni

2

1 reference

19 September 2017

Silvia Kochen

3

1 reference

19 September 2017

Patricia Saidon

4

1 reference

19 September 2017

publication date

26 February 2011

1 reference

European Journal of Clinical Pharmacology

19 September 2017

published in

1 reference

19 September 2017

volume

67

1 reference

19 September 2017

issue

5

1 reference

19 September 2017

page(s)

463-470

1 reference

Idiosyncratic adverse reactions to antiepileptic drugs

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Epidemiological study of severe cutaneous adverse drug reactions in a city district of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Severe adverse cutaneous reactions to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Immunoregulation of allergic contact dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Characterization of drug-specific T cells in lamotrigine hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Drug hypersensitivity to previously tolerated phenytoin by carbamazepine-induced DRESS syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Induction of hypersensitivity to a previously tolerated antiepileptic drug by a second antiepileptic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Human herpesvirus 6 and drug allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Stevens-Johnson syndrome and toxic epidermal necrolysis in Lomé (Togo). Evolutional and etiological profiles of 40 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Lamotrigine-associated rash: risk/benefit considerations in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Safety review of adult clinical trial experience with lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Children versus adults: pharmacokinetic and adverse-effect differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Predictors of Lamotrigine-associated rash

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1005-8

Adverse effects of antiepileptic drugs

21 January 2018

1 reference

12 December 2020

Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms.

1 reference

12 December 2020

Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

1 reference

12 December 2020

Lamotrigine-associated anticonvulsant hypersensitivity syndrome

1 reference

12 December 2020

Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6

1 reference

12 December 2020

10.1007/S00228-011-1005-8

Identifiers

DOI

1 reference

release_e3o2lfxsv5a6xf32aogqx6aw6m

19 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e3o2lfxsv5a6xf32aogqx6aw6m

24 November 2022

mapped directly with Wikidata item

1 reference